Page last updated: 2024-10-23

bumetanide and Sturge-Weber Syndrome

bumetanide has been researched along with Sturge-Weber Syndrome in 1 studies

Sturge-Weber Syndrome: A non-inherited congenital condition with vascular and neurological abnormalities. It is characterized by facial vascular nevi (PORT-WINE STAIN), and capillary angiomatosis of intracranial membranes (MENINGES; CHOROID). Neurological features include EPILEPSY; cognitive deficits; GLAUCOMA; and visual defects.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tyzio, R1
Khalilov, I1
Represa, A1
Crepel, V1
Zilberter, Y1
Rheims, S1
Aniksztejn, L1
Cossart, R1
Nardou, R1
Mukhtarov, M1
Minlebaev, M1
Epsztein, J1
Milh, M1
Becq, H1
Jorquera, I1
Bulteau, C1
Fohlen, M1
Oliver, V1
Dulac, O1
Dorfmüller, G1
Delalande, O1
Ben-Ari, Y1
Khazipov, R1

Other Studies

1 other study available for bumetanide and Sturge-Weber Syndrome

ArticleYear
Inhibitory actions of the gamma-aminobutyric acid in pediatric Sturge-Weber syndrome.
    Annals of neurology, 2009, Volume: 66, Issue:2

    Topics: Action Potentials; Bumetanide; Cerebral Cortex; Diazepam; Epilepsy; Excitatory Amino Acid Antagonist

2009